| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |